| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 137, 4161-4166, Copyright © 1996 by Endocrine Society
ARTICLES |
AE Calogero, N Burrello, P Negri-Cesi, L Papale, MA Palumbo, A Cianci, S Sanfilippo and R D'Agata
First Department of Internal Medicine, University of Catania, Italy.
It is a common clinical observation that stress is accompanied by dysfunction of the hypothalamic-pituitary-ovarian axis, and there is mounting experimental evidence that CRH, the principal regulator of ACTH release and the central coordinator of the stress response, is able to suppress gonadal function by inhibiting hypothalamic GnRH release. Recently, it has been shown that immunoreactive CRH, CRH messenger RNA, and CRH receptors are also present in the ovary. This prompted us to examine the role of CRH on ovarian function. To accomplish this, we studied the effects of this neuropeptide on estrogen production and cAMP intracellular content from rat granulosa and human granulosa-luteal cells. We also evaluated the activity of the enzyme aromatase by measuring the production of tritiated water from homogenates of cultured rat granulosa cells. CRH inhibited FSH- stimulated estrogen production from rat granulosa cells in a dose- dependent fashion. The maximal effect was achieved at a concentration of 10(-8) M, which suppressed estrogen production by about 30%. Low concentrations of CRH (10(-10) M), incapable of modulating maximal estrogen production in response to FSH, provoked a right-ward shift of the estrogen dose-response curve to FSH. CRH (10(-8) M) suppressed the production of tritiated water (equivalent to estrogen production) from homogenates of rat granulosa cells incubated with a half-maximal concentration of FSH. Basal estrogen production by human granulosa- luteal cells was also inhibited by CRH at a concentration of 10(-10) M. The maximal effect was achieved with a concentration of 10(-8) M, which lowered estrogen production by 25%. The CRH receptor antagonist alpha- helical CRH-(9-41) antagonized the inhibitory effect of CRH on estrogen production from rat granulosa and human granulosa-luteal cells, whereas alone it had no effect. CRH did not have any effect on the intracellular cAMP content of rat granulosa and human granulosa-luteal cells. In conclusion, these results suggest that CRH is able to suppress estrogen production from rat and human granulosa cells in vitro. This effect seems to be linked to inhibition of aromatase activity in the rat and is independent of cAMP generation. We speculate that CRH may also interfere with hypothalamic-pituitary-gonadal axis function by acting directly at the ovarian level.
This article has been cited by other articles:
![]() |
A. Yata, K. Nakabayashi, S. Wakahashi, N. Maruo, N. Ohara, and T. Maruo Suppression of progesterone production by stresscopin/urocortin 3 in cultured human granulosa-lutein cells Hum. Reprod., July 1, 2009; 24(7): 1748 - 1753. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xu, F. Xu, J. D. Hennebold, T. A. Molskness, and R. L. Stouffer Expression and Role of the Corticotropin-Releasing Hormone/Urocortin-Receptor-Binding Protein System in the Primate Corpus Luteum during the Menstrual Cycle Endocrinology, November 1, 2007; 148(11): 5385 - 5395. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mastorakos, E. I Karoutsou, and M. Mizamtsidi Corticotropin releasing hormone and the immune/inflammatory response Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S77 - S84. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. You, R. Yang, X. Tang, L. Gao, and X. Ni Corticotropin-Releasing Hormone Stimulates Estrogen Biosynthesis in Cultured Human Placental Trophoblasts Biol Reprod, June 1, 2006; 74(6): 1067 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Suzuki and R. J. Handa Regulation of Estrogen Receptor-{beta} Expression in the Female Rat Hypothalamus: Differential Effects of Dexamethasone and Estradiol Endocrinology, August 1, 2004; 145(8): 3658 - 3670. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Somboonporn and S. R. Davis Testosterone Effects on the Breast: Implications for Testosterone Therapy for Women Endocr. Rev., June 1, 2004; 25(3): 374 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Muramatsu, N. Sugino, T. Suzuki, K. Totsune, K. Takahashi, A. Tashiro, M. Hongo, Y. Oki, and H. Sasano Urocortin and Corticotropin-Releasing Factor Receptor Expression in Normal Cycling Human Ovaries J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1362 - 1369. [Abstract] [Full Text] |
||||
![]() |
K. Takegawa, K. Mitsumori, K. Yasuhara, M. Moriyasu, M. Sakamori, H. Onodera, M. Hirose, and T. Nomura A Mechanistic Study of Ovarian Carcinogenesis Induced by Nitrofurazone Using rasH2 Mice Toxicol Pathol, September 1, 2000; 28(5): 649 - 655. [Abstract] [PDF] |
||||
![]() |
A. Slominski, J. Wortsman, T. Luger, R. Paus, and S. Solomon Corticotropin Releasing Hormone and Proopiomelanocortin Involvement in the Cutaneous Response to Stress Physiol Rev, July 1, 2000; 80(3): 979 - 1020. [Abstract] [Full Text] [PDF] |
||||
![]() |
Corticotropin-Releasing Hormone: A Potent Androgen Secretagogue in Girls with Hyperandrogenism after Precocious Pubarche J. Clin. Endocrinol. Metab., December 1, 1999; 84(12): 4602 - 4606. [Abstract] [Full Text] |
||||
![]() |
B. N. Roy, R. L. Reid, and D. A. Van Vugt The Effects of Estrogen and Progesterone on Corticotropin-Releasing Hormone and Arginine Vasopressin Messenger Ribonucleic Acid Levels in the Paraventricular Nucleus and Supraoptic Nucleus of the Rhesus Monkey Endocrinology, May 1, 1999; 140(5): 2191 - 2198. [Abstract] [Full Text] |
||||
![]() |
H. F. Erden, I. H. Zwain, H. Asakura, and S. S. C. Yen Corticotropin-Releasing Factor Inhibits Luteinizing Hormone-Stimulated P450c17 Gene Expression and Androgen Production by Isolated Thecal Cells of Human Ovarian Follicles J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 448 - 452. [Abstract] [Full Text] |
||||
![]() |
R. Mancina, T. Barni, A. E. Calogero, S. Filippi, S. Amerini, A. Peri, T. Susini, G. B. Vannelli, N. Burrello, G. Forti, et al. Identification, Characterization, and Biological Activity of Endothelin Receptors in Human Ovary J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4122 - 4129. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ghizzoni, G. Mastorakos, A. Vottero, A. Barreca, M. Furlini, A. Cesarone, B. Ferrari, G. P. Chrousos, and S. Bernasconi Corticotropin-Releasing Hormone (CRH) Inhibits Steroid Biosynthesis by Cultured Human Granulosa-Lutein Cells in a CRH and Interleukin-1 Receptor-Mediated Fashion Endocrinology, November 1, 1997; 138(11): 4806 - 4811. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Asakura, I. H. Zwain, and S. S. C. Yen Expression of Genes Encoding Corticotropin-Releasing Factor (CRF), Type 1 CRF Receptor, and CRF-Binding Protein and Localization of the Gene Products in the Human Ovary J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2720 - 2725. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |